使用复合库申注射来治疗宫癌的可行性基于网络药理学和转录学
Yiting Zhang1, Linjing Xu, Ling Li
1Department of Gynecology, Zhaoqing First People's Hospital, Zhaoqing, China.
Medicine
|September 8, 2023
概括
复合库申注射 (CKI) 通过向CXCL2等关键基因,抑制癌细胞生长并通过多种途径促进细胞亡,有效治疗宫癌.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 基因组学就是基因组学.
背景情况:
- 宫癌仍然是一个重大的全球健康挑战.
- 了解复合库申注射 (CKI) 等传统药物的分子机制对于开发新的治疗策略至关重要.
研究的目的:
- 阐明CKI在宫癌预防和治疗中的分子标和机制.
- 整合网络药理学和转录学以全面识别目标.
主要方法:
- 网络药理学被用来识别活性化合物和预测标.
- RNA测序数据与网络药理学结果相结合,以选和验证目标基因.
- 进行了蛋白质与蛋白质相互作用 (PPI) 网络分析,以确定枢纽基因.
- 生物实验,包括分子对接,RT-PCR和西部污染,用于验证.
主要成果:
- 鉴定出CXCL2,抗血管内皮生长因子和赫索金酶2是宫癌中CKI的关键治疗标.
- 这些目标在与癌症相关的途径中得到显著丰富,包括癌症,细胞循环和MAPK信号传递中的途径.
- 在体外研究表明,CKI抑制宫癌细胞的增殖,促进细胞亡,并诱导细胞循环停止.
- 经过RT-PCR和Western blot证实,在CKI治疗后,枢纽基因表达显著下降,并观察到良好的结合活性.
结论:
- 在宫癌中,CKI通过多目标,多途径的方法来发挥其治疗效果.
- 通过诱导细胞循环停止和亡,CKI有效地阻止了宫癌细胞的生长.
- 这些发现证实了CKI在治疗宫癌中的有效性.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
190
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
190